outcome of cystic fibrosis in patients with bronchiectasis

Authors

nemat bilan pediatric health research centre, tabriz university of medical sciences, tabriz, iran.

mitra agakhani pediatrician.

mahmood goldost general practitioner

abstract

introduction: bronchiectasis is a common problem in children especially under 5 years. early diagnosis of disease and its causes could be useful in early treatment and preventing probable complications. this study aimed at evaluating the cystic fibrosis (cf) in patients with  bronchiectasis. methods: in a cross-sectional study, 374 children with bronchiectasis were studied. the diagnosis was made according to clinical (chronic cough and persistent sputum) and ct scan findings. demographic findings, clinical findings, treatment, etiology, imaging and outcome of dieses were recorded. results: two-hundred-and-forty (64.2%) were male with mean age of 8.61±3.36 years at the diagnosis. in patients with and without the etiology of cf, the cure was observed in 1 (5.6%) and 132 (37.1%), partial remission in 5 (27.8%) and 148 (41.6%) of the cases and non improvement in 12 (66.7%) and 76 (21.3%). there was significant relation between existence of asthma (p<0.001), gerd (p=0.02) and cf (p<0.001) with response to treatment in bronchiectasis. conclusion: bronchiectasis is common in infants with the etiology of cf and cure and partial remission is lower in cf patients who have bronchiectasis.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Outcome of Cystic Fibrosis in Patients with Bronchiectasis

Introduction: Bronchiectasis is a common problem in children especially under 5 years. Early diagnosis of disease and its causes could be useful in early treatment and preventing probable complications. This study aimed at evaluating the cystic fibrosis (CF) in patients with  bronchiectasis. Methods: In a cross-sectional study, 374 children with bronchiectasis were studied. The diagnosis was ma...

full text

Non-cystic fibrosis bronchiectasis.

Bronchiectasis is characterized by irreversible widening of the medium-sized airways, with inflammation, chronic bacterial infection and destruction of the bronchial walls. Exercise or inspiratory muscle training may improve quality of life and exercise endurance in people with non-cystic fibrosis bronchiectasis. Prolonged-use antibiotics improve clinical response rates, but may not reduce exac...

full text

Non-cystic fibrosis bronchiectasis.

Bronchiectasis is a chronic debilitating condition with considerable phenotypic diversity. A vicious cycle of infection and inflammation exists in damaged airways with patients suffering from persistent cough, purulent sputum production, recurrent chest infections and general malaise. The associated burden of disease in terms of increased morbidity, reduced quality of life and the socioeconomic...

full text

Adrenal insufficiency in patients with stable non-cystic fibrosis bronchiectasis

BACKGROUND & OBJECTIVES Suppressed adrenal responses associated with inhaled steroid use have been reported in patients with bronchiectasis and have been shown to be associated with poor quality of life. This study was undertaken to examine the prevalence of suppressed cortisol responses in stable bronchiectasis and determine their correlation with the use of inhaled corticosteroids, radiologic...

full text

Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis

Background Aspergillus sensitization (AS) and allergic bronchopulmonary aspergillosis (ABPA) can occur as a cause of permanent lung damage in patients with cystic fibrosis (CF) and non-CF bronchiectasis. Objective The aim of this study was to determine the frequency of AS and ABPA in patients with CF and non-CF bronchiectasis in southwestern Iran. Methods This cross-sectional study was cond...

full text

My Resources

Save resource for easier access later


Journal title:
international journal of pediatrics

جلد ۲، شماره ۴.۱، صفحات ۳۱۳-۳۱۸

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023